PBM Impact On Off-Patent Industry Condemned At Senate Hearing
Discussion Before US Senate Finance Committee Has Been Praised By The Biosimilars Forum
PBM practices make it harder for patients to acquire cheaper off-brand medication • Source: Shutterstock 
